CraddockP., FehrJ., BrighamK., KronenbergR., JacobH.. Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis. N Eng J Med1977; 296: 769–74.
FalkenhagenD., BoschT., BrownG.A clinical study on different cellulosic membranes. Nephrol Dial Transplant1987; 2: 537–45.
4.
SmebyL., WideroeT., BalstadT., JorstadS.. Biocompatibility aspects of cellophane, cellulose acetate, polyacrylonitrile, polysulfone and polycarbonate hemodialyzers. Blood Purification1986; 4: 93–101.
5.
SakashitaK., TutuiT., YamamotoN.Clinical investigation on biocompatibility for three kinds of modified cellulose haemodialysis membranes. Jpn J Artif Organs1991; 20: 85–90.
6.
ArnaoutM., HakimR., ToddR., DanaN., ColtenH.. Increased expresson of an adhesion-promoting surface glycoprotein in the granulocytopenia of hemodialysis. N Engl J Med1985; 312: 457–62.
7.
CristolJ., CanaudB., RabesandratanaH., GaillardI., SerreA., MionC.. Enhancement of reactive oxygen species production and cell surface markers expression due to haemodialysis. Nephrol Dial Transplant1994; 9: 389–94.
8.
HimmelfarbJ., ZaouiP., HakimR.. Modulation of granulocyte LAM-1 and MAC-1 during dialysis - a prospective, randomized controlled trial. Kidney Int1992; 41: 388–95.
9.
LundahlJ., HedJ., JacobsonS.. Dialysis granulocytopenia is preceded by an increased surface expression of the adhesion-promoting glycoprotein Mac-1. Nephron1992; 61: 163–9.
10.
StuardS., CarrenoM P., PoignetJ P., AlbertazziA., Haeffner-CavaillonN.. A major role for CD62P/CD15s interaction in leukocyte margination during hemodialysis. Kidney Int1995; 48: 93–102.
11.
TielemansC., DelvilleJ., HussonC., MadhounP., LambrechtsA., GoldmanM., VanherweghemJ.. Adhesion molecules and leukocyte common antigen on monocytes and granulocytes during hemodialysis. Clin Nephrol1993; 39: 158–65.
12.
ThylénP., LundahlJ., FernvikE., HedJ., SvensonS., JacobsonS.. Mobilization of an intracellular glycoprotein (Mac-1) on monocytes and granulocytes during hemodialysis. Am J Nephrol1992; 12: 393–400.
13.
AlvarezV., PulidoR., CampaneroM., ParaisoV., De LandázuriM., Sánchez-MadridF.. Differentially regulated cell surface expression of leukocyte adhesion receptors on neutrophils. Kidney Int1991; 40: 899–905.
14.
CarrenoM., StuardS., BonominiM.Cell-associated adhesion molecules as early markers of bioincompatibility. Nephrol Dial Transplant1996; 11: 2248–57.
15.
Von AppenK., GoolsbyC., MehlP., GoewertR., IvanovichP.. Leukocyte adhesion molecules as biocompatibility markers for hemodialysis membranes. ASAIO J1994; 40: M609–15.
16.
DhondtA., VanholderR., WaterloosM., GlorieuxG., De SmetR., LameireN.. Citrate anticoagulation does not correct cuprophane bioincompatibility as evaluated by the expression of leukocyte surface molecules. Nephrol Dial Transplant1998 (in press).
17.
KaupkeC., ZhangJ., CesarioT., YousefiS., AkeelN., VaziriN.. Effect of hemodialysis on leukocyte adhesion receptor expression. Am J Kidney Dis1996; 27: 244–52.
18.
CheungA., MohammadS., LeypoldtJ.. Adhesion molecules and artificial membranes. In: PaulL.C., IssekutzT.B., eds. Adhesion molecules in health and disease.New York: Marcel Dekker, 1997; 643–78.
19.
PulidoR., AlvarezV., MollinedoF., Sánchez-MadridF.. Biochemical and functional characterization of the leucocyte tyrosine phosphatase CD45 (CD45RO, 180 kD) from human neutrophils. In vivo upregulation of CD45RO plasma membrane expression in patients undergoing haemodialysis. Clin Exp Immunol1992; 87: 329–35.
20.
DhondtA., VanholderR., WaterloosM., GlorieuxG., RingoirS.. Leukocyte CD14 and CD45 expression during hemodialysis: polysulfone versus cuprophane. Nephron1996; 74: 342–8.
PhilipsM., BuyonJ., WinchesterR., WeissmannG., AbramsonS.. Up-regulation of the iC3b receptor (CR3) is neither neces-sary nor sufficient to promote neutrophil aggregation. J Clin Invest1988; 82: 495–501.
23.
ThylénP., FernvikE., LundahlJ., HedJ., JacobsonS.. Modulation of CD11b/CD18 on monocytes and granulocytes following hemodialysis membrane interaction in vitro.Int J Artif Organs1996; 19: 156–63.
24.
GardinaleM., CicardiM., AgostoniA., HugliT.. Complement activation in extracorporeal circulation: physiological and pathological implications. Pathol Immunopathol Res1986; 5: 352–70.
25.
ChenowethD., CheungA., HendersonL.. Anaphylatoxin formation during hemodialysis: effects of different dialyzer membranes. Kidney Int1983; 24: 764–9.
26.
JagelsM., ChambersJ.D., ArforsK., HugliT.. C5a- and tumor necrosis factor-α-induced leukocytosis occurs independently of β2 integrins and L-selectin: differential effects on neutrophil adhesion molecule expression in vivo.Blood1995; 85: 2900–9.
27.
WerfelT., OppermannM., SchulzeM., KriegerG., WeberM., GötzeO.. Binding of fluorescein-labeled anaphylatoxin C5a to human peripheral blood, spleen, and bone marrow leukocytes. Blood1992; 79: 152–60.
28.
HimmelfarbJ., HolbrookD., Mc MonagleE.. Effects of apoprotein on complement and granulocyte activation during ex vivo hemodialysis. Am J Kidney Dis1994; 24: 901–6.
29.
HimmelfarbJ., McMonagleE., HolbrookD., TothC.. Soluble complement receptor 1 inhibits both complement and granulocyte activation during ex vivo hemodialysis. J Lab Clin Med1995; 126: 392–400.
30.
TettaC., SegoloniG., PacittiA.The production of platelet-activating factor during hemodialysis. Int J Artif Organs1989; 12: 766–72.
31.
SakaguchiK., MorimotoS., ChenY., NakamotoY., OgiharaT.. Increases in circulating level of platelet-activating factor lag behind transient neutropenia during hemodialysis with cuprophane membranes. Nephron1991; 59: 455–60.
32.
TettaC., TropeaF., CamussiG.Adherence of human monocytes to haemodialysis membranes: LFA1 (CD11a/CD18), CR1 (CD35) and CR3 (CD11b/CD18) triggering promotes the biosynthesis of platelet-activating factor and adherence. Nephrol Dial Transplant1995; 10: 1679–88.
33.
GrootemanM., BosJ., van HouteA., van LimbeekJ., SchoorlM., NubéM.. Mechanisms of intra-dialyser granulocyte activation: a sequential dialyser elution study. Nephrol Dial Transplant1997; 12: 492–9.
HakimR., WingardR., ParkerR.. Effect of the dialysis membrane in the treatment of patients with acute renal failure. N Engl J Med1994; 331: 1338–42.
36.
HartmannJ., FrickeH., SchifflH.. Biocompatible membranes preserve residual renal function in patients undergoing regular hemodialysis. Am J Kidney Dis1997; 30: 366–73.
37.
Van LooA., VanholderR., BernaertP., VermassenF., Van Der VennetM., LameireN.. Pretransplant hemodialysis strategy influences early renal graft function. J Am Soc Nephrol1998 (in press).
38.
KellyK., WilliamsW., ColvinR., BonventreJ.. Antibody to intracellular adhesion molecule 1 protects the kidney against ischemic injury. Proc Natl Acad Sci USA1994; 91: 812–6.
39.
LevinN., ZasuwaG., DumlerF.. Effect of membrane type on causes of death in hemodialysis patients (abstract). J Am Soc Nephrol1991; 2: 335.
40.
HornbergerJ., ChernewM., PetersenJ., GarberA.. A multivariate analysis of mortality and hospital admissions with high-flux dialysis. J Am Soc Nephrol1992; 3: 1227–37.
41.
VanholderR., RingoirS., DhondtA., HakimR.. Phagocytosis in uremic and hemodialysis patients: a prospective and cross sectional study. Kidney Int1991; 39: 320–7.
42.
PinnickR., WiegmannT., DiederichD.. Regional citrate anticoagulation for hemodialysis in the patient at high risk for bleeding. N Engl J Med1983; 308: 258–61.
43.
BöhlerJ., SchollmeyerP., DresselB., DobosG., HörlW.. Reduction of granulocyte activation during hemodialysis with regional citrate anticoagulation: dissociation of complement activation and neutropenia from neutrophil degranulation. J Am Soc Nephrol1996; 7: 234–41.
44.
SeatonR., DuncanK., PinnickR., DiederichD., WiegmannT.. Regional citrate anticoagulation in chronic hemodialysis patients. Trans ASAIO1983; 29: 414–8.
45.
WiegmannT., MacDougallM., DiederichD.. Dialysis leukopenia, hypoxemia and anaphylatoxin formation: effect of memebrane, bath, and citrate anticoagulation. Am J Kidney Dis1988; 11: 418–24.
46.
JanssenM., HuijgensP., BoumanA., OeP., DonkerA., Van Der MeulenJ.. Citrate versus heparin anticoagulation in chronic haemodialysis patients. Nephrol Dial Transplant1993; 8: 1228–33.
47.
JanssenM., DeegensJ., KapingaT., BeukhofJ., HuijgensP., Van LoenenA., Van Der MeulenJ.. Citrate compared to low molecular weight heparin anticoagulation in chronic hemodialysis patients. Kidney Int1996; 49: 806–13.
48.
Van WykV., BadenhorstP., KotzéH.. The effect of r-hirudin vs. heparin on blood-membrane interactions during hemodialysis. Clin Nephrol1997; 48: 381–7.
